ExpertCare

A high impact medicines optimisation solution for CVD risk management

ExpertCare helps primary care teams reduce CVD risk by optimising prescribing for patients with long-term conditions (i.e. hypertension, lipid management) — right from within their workflow.

Every three minutes, someone in the UK dies of a heart attack or stroke. Many deaths are premature and could have been avoided if patients had been optimally treated.

We Can Help You To:

Cardiovascular risk often goes unseen in primary care. Many patients with hypertension and high cholesterol are undertreated, while clinicians face limited time and information overload. The result: preventable heart attacks, strokes, and lost QOF points.

Reduce CVD risk with evidence-based prescribing recommendations

Boost QOF performance and practice income

Save time on medicine reviews

Ease practice pressure and free up clinical capacity

Every Minute Counts - A Smarter Way to Optimise Medicines

Cardiovascular risk often goes unseen in primary care. Many patients with hypertension and high cholesterol are undertreated, while clinicians face limited time and information overload. The result: preventable heart attacks, strokes, and lost QOF points.

Save Time

Faster, guided decisions at the patient’s record.

Ensure best practice

Recommendations aligned with NICE and local guidelines.

Improve outcomes

Optimised treatment reduces cardiovascular risk and improves patient safety.

Select your role to see how we can support you:

GP / Pharmacist

Smarter prescribing. Less time.

Identify, optimise, and hit QOF goals fast.
Contact us

Practice Manager

Simplify workflows. Boost results.

Save time, lift QOF scores, cut pressure.
Contact us

ICB Lead / Commissioner

Reduce CVD risk at scale.

Drive measurable impact across practices.
Contact us

Every Minute in Primary Care Counts — But CVD Risk Often Goes Unseen

Missed Opportunities

Thousands of patients remain undertreated for hypertension and lipid management.

A System Under Pressure

Limited time and growing demand lead to unoptimised therapy.

Information Overload

Too many alerts and data points make prioritising the right patients difficult.

The Result: preventable heart attacks and strokes — and missed QOF points.

Hypertension and hypercholesterolemia control remains an unmet challenge

CVD drives a dual burden of personal suffering and heavy NHS costs

CVD is a leading cause of death and disability in the UK. Though preventable and treatable, late diagnosis and poor management fuel avoidable admissions, higher costs, and health inequalities – making new system-wide hypertension models essential.

Every Minute Counts - A Smarter Way to Optimise Medicines

Cardiovascular risk often goes unseen in primary care. Many patients with hypertension and high cholesterol are undertreated, while clinicians face limited time and information overload. The result: preventable heart attacks, strokes, and lost QOF points.

A new approach - systemised and automated virtual care works

By automating elements of decision-making and integrating seamlessly with EMIS and SystmOne, ExpertCare enhances workforce productivity, ensures NICE concordance, and enables system-level efficiencies.

A Smarter Way to Do Medicines Optimisation, From Data to Decision in Seconds

Analyse

Patient’s coded record — instantly identifies risk factors and gap

Apply

Cross-checks records with the latest NICE guidance and best-evidence advice.

Recommend

Suggests optimised, evidence-based treatment options tailored to each patient.

How It Works

In the clinician workflow, at the point- of-care

ExpertCare is a fast, easy-to-use digital solution that supports clinicians in personalised, evidence-based CVD medicines optimisation by using patient context to enable precise and timely prescribing decisions. It considers:

Comorbidities • therapeutic history • current clinical status • guidelines

Lowestoft PCN: An Example of Success

Lowestoft Hypertension (Healthy Hearts) project. A HTN meds review of 3,600 patients in 7 GP practices over 8-months (Nov 2024 – July 2025). Results: 85.5% of responding patients achieved BP control due to the intervention together with an average drop of 21 mmHg in Systolic and mmHg 10.3 in Diastolic, in patients who had uncontrolled hypertension after first review.

7 GP practices

3.600 patients

85.5% BP control rate achieved

21 mmHg Systolic and 10.3 mmHg diastolic reduction in cohort mean BP

Supports Task-Shifting And Reduces Variation In Care

ExpertCare combines a rules-based AI optimisation engine with pharmacist-led implementation methodologies to streamline and speed up CVD medicines review and optimisation prescribing.  

Tailored patient prescribing

Automatically considers patient demographics and history

Personalised prescribing optimisation is reliant on having access to the right information at the right time. Our super-fast clinical codes search capabilities together with our certified Electronic Health Record integration API gives prescribers instant access to the vital patient information needed to make an accurate prescribing decision.

Ensures compliance with gold standard guidelines

Medicines is the most common intervention in healthcare and proper medicines prescribing is complicated especially when treating multiple conditions in a single patient. ExpertCare’s digital protocol-driven medication optimisation and intensification solution helps translate evidence-based guidance into common practice ensuring cost-effective treatment outcomes.

Boosts task-shifting and lightens the GP load

Our solution is designed to take the strain of chronic condition medicines management off primary care doctors by boosting task-shifting and empowering nurses and pharmacists to undertake complex prescribing. It bridges gaps in clinician knowledge of evidence-based therapeutic guidelines and reduces variation in healthcare delivery leading to significant gains in patient treatment outcomes and avoids unnecessary costs.

Clinical safety, data accuracy and security vital to our approach

The solution has been co-designed with frontline clinicians and health system partners through iterative development and independent usability studies, confirming its intuitiveness, clinical relevance, and benefits for complex patients.

Our health industry standards compliant APIs allows for seamless integrations with leading Electronic Health Records solutions. ExpertCare meets all NHS data and other regulatory requirements including NHSE, MHRA and DTAC.

Evidence shows ExpertCare is cost-saving in both the short- and long-term

Independent evaluations, show ExpertCare delivers immediate and long-term savings, halving the cost of hypertension and cholesterol reviews. Across thousands of patients, it consistently improves blood pressure control (average 20mmHg systolic reduction in uncontrolled patients), achieves an ROI of £2.60 per £1 spent, and reduces vascular events—extending life expectancy and narrowing health inequalities.

Medicines Optimisation. When Everyone Benefits.

Ensuring that patients are prescribed the right medicines, at the right time, in the right doses.

Lowering blood pressure and lipids reduces the risk of heart disease, stroke and death

It’s about you, me, and the ones we love

ExpertCare ensures optimum therapeutic outcomes for patients through improved medication use and reduces the risk of adverse events. Our patient-centered process creates treatment plans focused on each patient’s medication-related goals. This eliminates variations and inequalities in care.

Alleviates GP practice pressures

Boosts practice productivity and income

Beyond improving outcomes, ExpertCare saves clinician time and costs, empowers pharmacy teams with evidence-based recommendations, standardised workflows, and robust analytics to reduce risk, optimise therapy, and enhance patient care.

"Cardiovascular disease (CVD) detection and management is the most impactful area for saving lives over the next decade."

Source: NHS England

Suboptimal medicine use drives hospitalisations, costs, and poor adherence. Improving prescribing and monitoring enhances outcomes, efficiency, and ensures patients and healthcare payers gain greater value from investments in medicines and care.

Safe, Secure and Scalable for Every Care Setting

1.

Integrated with EMIS Web and SystmOne

2.

Hosted in UK-based, NHS-approved environments

3.

Compliant with NHS DTAC, UK GDPR, and ISO 27001

Outcomes are transparent, measurable, and contractually defined, with embedded tracking systems providing auditable data across patient engagement, control rates, NICE compliance, and practice resource utilisation.

2022

The Test: An ExpertCare Beta test project involving six hypertension specialists in five different practices.

Results: User feedback used to drive iterative improvements in the innovation and workflow.

2023

The NIHR Evaluation

A formal real world evaluation funded by a NIHR Innovation (i4i) at the Speed of Translation (FAST) programme and in collaboration Health Innovate East. Involved 300 patients across 4 GP practices.

Results:  Confirmed that patients treated in concordance with NICE guidance are more likely to have controlled BP.

2023/24

The Innovate UK Evaluation

An 18-month-long full-blown real-world evaluation involving Health Innovation East and Innovate UK across 10 GP practice and involving 2 000 patients to evidence ExpertCare’s efficacy and cost-effectiveness in managing uncontrolled hypertensive patients to BP control. Results: EC is cost-effective in both the long- and short-term in managing HTN patient to BP control – ROI – £2.60 return for every £1 invested – excludes savings in heart attacks and strokes prevented.

2024/25

Healthy Hearts Implementation

Lowestoft Hypertension (Healthy Hearts) project. A HTN meds review of 3,600 patients in 7 GP practices over 8-months.

Results: 85.5% of responding patients achieved BP control due to the intervention together with an average drop of 21 mmHg in Systolic and mmHg 10.3 in Diastolic, in patients who had uncontrolled hypertension after first review.

From Evidence to Action

ExpertCare has been extensively tested in real-world settings, proving its clinical value, seamless workflow integration, and ability to generate the evidence needed for wider commissioning. Co-designed with frontline clinicians and health system partners, and refined through independent usability studies, it is intuitive, clinically relevant, and effective for managing complex patients.

Safe, Secure and Scalable for Every Care Setting Integrated with EMIS Web and SystmOne Hosted in UK-based, NHS-approved environments Compliant with NHS DTAC, UK GDPR, and ISO 27001

Whether a single GP practice, a Primary Care Network, Neighbourhood or ICS, ExpertCare  offers a range of flexible deployment models—standalone, turnkey, or mentored—ensuring that health system – big or small can adopt the solution in alignment with resources and priorities.

1.

Solution only:

The practice conducts the process in-house, supported by EC, with a flat per-patient fee covering solution support and maintenance.

2.

Turnkey service:

DXS delivers a complete “virtual always” hypertension control programme using contracted clinical pharmacists, priced per registered patient.

3.

Mentor mode:

A blended approach where PCNs provide staff (e.g. ARRS-funded pharmacists or prescribing nurses) while DXS supplies training, mentorship, and project management, with a per-patient fee.

Outcomes are transparent, measurable, and contractually defined, with embedded tracking systems providing auditable data across patient engagement, control rates, NICE compliance, and practice resource utilisation.

About Us

ExpertCare is developed by DXS International plc, a UK-based company with deep expertise in healthcare technology. We design, deploy, and support trusted digital solutions that help NHS teams deliver better care.

As an NHS-accredited supplier, DXS provides clinical decision support tools listed on the Primary Care GPIT-F Framework and used in over 2,000 primary care sites across the UK, supporting more than 17 million patients.

Behind ExpertCare is a dedicated team of clinicians, developers, and healthcare specialists focused on empowering primary care teams to make faster, evidence-based decisions for better patient outcomes.

What ExpertCare Users Have To Say

Frequently asked questions

All your questions answered.

What is ExpertCare?

DXS ExpertCare is an expert system which provides prescribing advice with the dual objectives of controlling the patient’s blood pressure to an appropriate target, whilst also achieving conformance with treatments recommended by NICE for the management of hypertension and relevant comorbidities.

Unlike other clinical decision support software which makes recommendations based on one comorbidity at a time, ExpertCare will make a recommendation based on any combination of the following conditions:

  • Diabetes (all types)
  • Proteinuria (defined as an ACR › 30)
  • Angina
  • Myocardial Infarction (recent (i.e. ‹ 1year) and past (i.e. › 1year))
  • Atrial fibrillation
  • Heart failure

ExpertCare thus overcomes one of the main criticisms of NICE, that the guidelines are monothematic, and therefore difficult to implement in real-world situations where patients have comorbidities.

The six conditions listed above have been chosen for the following reasons:

  • They have a significant impact on hypertension treatment decisions
  • NICE makes recommendations on appropriate prescribing for these conditions
  • Hypertension management needs to consider the wider risks conferred by comorbidity

ExpertCare interprets the patient’s coded electronic record to infer the presence of any condition which might influence the treatment of hypertension and provides context sensitive advice taken from the SPC of all drugs used in the treatment of hypertension.

The clinician is notified of

  • Drug indications, cautions and contraindications
  • Advice on initiation, monitoring and discontinuation
  • Routine dosage advice
  • Dose adjustments required in the presence of renal or hepatic impairment

However, it is up to the prescriber to evaluate this information based on clinical context. For example, childhood asthma might be a caution to the issue of a beta-blocker whereas current asthma would be a contraindication.

The prescriber can continue a hypertension drug for any indication but will be asked for a reason which will be recorded for the benefit of future users. Further recommendations by ExpertCare will take into consideration the retained drug. For example, clonidine retained for the prophylaxis of migraine.

ExpertCare does not duplicate the functionality of the GP healthcare record where interactions are highlighted when a new drug is added. In our next version of ExpertCare, we will add warnings to flag up the risk of bradycardia with certain drug combinations. Similarly, we will also indicate when there is an increased likelihood of hyperkalaemia.

ExpertCare will record the reason for not taking a drug class to inform future consultations. The clinician can then ask for a further recommendation.

In this situation, ExpertCare is sophisticated in that it always makes recommendations which support the effective management of relevant comorbidity. For example, a patient with hypertension and atrial fibrillation, who opts not to take a beta-blocker, will be recommended a rate-limiting calcium channel blocker instead.

ExpertCare has the functionality to indicate a drug which belongs to a local formulary.

The ExpertCare Process

1.

Each month the hypertension register is used to produce a cohort of patients to review

2.

Admin person contacts patients for updated BP by SMS/phone

3.

Responses saved to patients record

4.

Pharmacist conducts a medicines review for each uncontrolled patient using ExpertCare

5.

Clinician saves new treatment plan to patient’s record

6.

Approval sought for medicine changes

7.

Pharmacist updates prescribing module and sets next review reminder

CVD medicines optimisation using Standard Care

Most GP practices continue to manage CVD at-risk patients through a traditional “standard care” model. In this approach, administrative staff oversee call and recall for blood pressure reviews, patients attend the practice to have their blood pressure and occasionally other tests carried out by a nurse or healthcare assistant, and, when medication adjustments are required, they are referred on to already overstretched GPs for review.

The problem:

Key barriers to optimal care include an increasing number of CVD patients (aging population), and the absence of a focused, systemised and automated review methodology. This is compounded by pressures on primary care and clinician time constraints, guideline complexity, and insufficient decision support tools.

CVD medicines optimisation using Virtual Care Model

Patients are risk-stratified and prioritised for review. Updated blood pressures are collected remotely via SMS or telephone, while cholesterol monitoring is arranged through blood test requests. Once results are received, patients needing medication changes are reviewed virtually: a proposed adjustment is made, patient consent obtained, the prescription updated, and the patient informed with a new review date scheduled.

Why it works:

Our solution is designed to take the strain of CVD medicines management off primary care doctors by automating processes, boosting task-shifting and empowering nurses and pharmacists to undertake complex prescribing. Critically, our virtual care model is designed to extend care into patients’ homes, overcoming barriers faced by hard to reach or deprived and underserved populations where hypertension incidence and stroke risk are disproportionately high.

Massive reductions in cardiovascular events

A meta-analysis study showed that a 10 mm Hg reduction of systolic blood pressure reduced the risk of:

  • Major cardiovascular disease events by 20%
  • Coronary heart disease by 17%
  • Stroke by 27%
  • Heart failure by 28%,
  • Death from all causes by 13%.

The study strongly supports offering drug treatments to reduce systolic blood pressure levels to less than 130 mm Hg to all people regardless of whether they have a history of cardiovascular disease, diabetes or chronic kidney disease.

Taking strain off GP practices

ExpertCare (EC) is designed to take the strain of CVD medicines management off primary care clinicians by automating processes, boosting task-shifting and empowering nurses and pharmacists to undertake complex prescribing. It enhances primary care efficiency—a critical capability given the global shortage of clinical staff. It cuts the cost of HTN and cholesterol medicine reviews by 50% compared to usual care.

Generates financial rewards for GP practices

The platform directly supports achievement of QOF targets, which increasingly prioritise hypertension and cholesterol management. Meeting these targets not only improves patient outcomes but also secures vital financial incentives.

The CVD toll

In England (2019/20), CVD accounted for about 1 million hospital admissions leading to 5.5 million bed days. CVD related conditions cost the health system an estimated £7.4 billion and the economy an estimated £15.8 billion a year. One in 6 people will have a stroke during their lifetime and social care costs to the UK economy for stroke survivors are estimated at £5.2 billion annually.

Saving lives and money

NHS England estimates that increasing the proportion of people with hypertension who are well-managed from 70% to 80% in 3 years would lead to nearly 2.24 million fewer healthcare episodes 167 across primary care, outpatients and inpatients over a 10-year period, freeing up GPs and contributing to progress on elective waiting times. And, increasing lipid management rates to 90% of people with CVD currently untreated with statins could prevent ~14,000 heart attacks, strokes and deaths over 3 years.